Hemodialysis and Peritoneal Dialysis Market -
The lucrative way to manage renal health
The innovations
in the medical field has developed several business opportunities. One such
lucrative profit making medical domain is hemodialysis and peritoneal dialysis.
Few of the data written below is the testimony that the market is going to
flourish.
Startling facts-
Ø As per a report
by the WHO in 2019, kidney diseases accounted for 254,028 total deaths, 131,008
deaths in men, and 123,020 deaths in women.
Ø Chronic kidney
disease (CKD) affects more than 10% of the general population worldwide, which
comes close to 800 million individuals.
Ø Older
individuals, women, racial minorities, and people with health conditions such
as diabetes mellitus and hypertension are more susceptible to kidney problems.
Ø Kidney disease
is most common in people aged between 65 to 74 years. 25% of the people younger
than 60 years also experience kidney problems
Ø Non-communicable
diseases (such as heart disease, diabetes, or kidney disease) have become the
most common causes of premature death worldwide.
Ø An estimated
80% of this health burden occurs in low or middle-income countries.
Ø
Request
Report Sample@ https://www.researchnester.com/sample-request-4271
What is kidney malfunction?
The kidneys
filter waste and excess fluid from the blood. When kidneys fail to perform
their function, waste builds up. Symptoms may not show any specification of the
disease or may appear slowly or may not appear at all but are diagnosed by a
lab test. In advanced stages, dangerous levels of fluid, electrolytes, and
wastes build up in the body leading to chronic kidney disease. At this stage, filtering of the blood with a
machine (dialysis) at fixed intervals is required to avoid or postpone a kidney
transplant.
Dialysis- a medical boon for kidney patients
Dialysis is a
procedure through which waste products and excess fluids are removed from the
blood to restrict their accumulation. In the case of chronic kidney disease, waste,
and fluid can rise to dangerous levels causing unpleasant symptoms and even
death, hence filtering or dialysis needs to be done by diverting the blood to a
machine that cleans it.
Types of Dialysis
There are 2
main types of dialysis namely - hemodialysis and peritoneal dialysis.
Hemodialysis is the most common type of dialysis, in which a
tube is attached to a needle in the arm through which the blood passes into an
external machine that filters it. It is passed back into the arm through
another tube.
·
At dialysis centers, this is usually carried out 3 days a
week, with each session lasting around 4 hours.
·
At home, it can be done as per any of the following schedules
v 4 times a week
for 4 hours
v 5 times a week
for 3 hours
v 6 days a week
for 8 hours overnight
In Peritoneal Dialysis, the inside lining
of the patient’s belly acts as a natural filter. A soft plastic tube called a catheter
is placed in the abdomen surgically and the abdominal area is filled with dialysate,
which is a cleansing fluid. Wastes are taken out by washing in and out of the
belly in cycles. After the filtering process is finished, the fluid flows out
of the body through the catheter.
Hemodialysis and Peritoneal Dialysis –Market Research Synopsis
The
current, estimated size and growth rate (CAGR) of the Hemodialysis
and Peritoneal Dialysis Market
The global hemodialysis and
peritoneal dialysis market size was valued at USD 89.2 billion as of 2022 and
is expected to reach USD 160.5 billion growing at a compound annual growth rate
(CAGR) of 7% from 2023 to 2035.
Trends positively favoring the market
growth
v The
growing incidence of chronic kidney disease (CKD) globally - An estimated 1 million people worldwide
die from untreated kidney failure each year. According to the Centers for Disease Control
and Prevention (CDC), more than 15% of U.S. adults are estimated to have CKD as
of 2022.
v The
increasing geriatric population worldwide- The share of the population aged 60 years and over is anticipated
to increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the world's
population of people aged 60 years and older is expected to reach 2.1 billion.
v The high
prevalence of diabetes and hypertension- In 2021, Approximately 537 million adults (20-79 years) are living
with diabetes. The total number of people living with diabetes is projected to
rise to 643 million by 2030 and 783 million by 2045.
v The
introduction of innovative and advanced home-dialysis techniques- Technological advancements in the field
of home-care dialysis have facilitated convenience
with better efficacy in procedures.
v The
spurt in collaborations and strategic developments by key players- Major players are collaborating and
entering into strategic agreements for strengthening their positions in the
market.
Trends negatively impacting the market
growth
Ø The high capital investments involved in innovation
and product development
Ø The cumbersome procedures for regulatory
approval
Ø Stiff competition amongst market players
and the difficulty in sustenance for small and medium-sized companies.
Research Nester recently published an article with a
detailed and in-depth analysis of the Hemodialysis and
Peritoneal Dialysis Market
The
prominent players in the Hemodialysis
and Peritoneal Dialysis Market Industry are-
Baxter; B. Braun Melsungen AG; Fresenius
Medical Care AG; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Corp.; DaVita
Inc.; Nikkiso Co., Ltd.; and Cantel Medical.
Latest Developments in the field
Ø Fresenius Medical Care has closed the three-way merger including Fresenius
Health Partners, forming the new company, with the brand name InterWell Health.
It has satisfied customary closing conditions and received regulatory clearance
in the U.S. InterWell Health’s clinical
care models with a strong network of 1,700 nephrologists and Cricket Health’s
tech-enabled care model and patient engagement platforms have created an
innovative, stand-alone entity poised to transform kidney care.
Ø DaVita Inc has expanded its home kidney care program and added the HomeChoice
Claria Automated Peritoneal Dialysis (APD) system enabled by Sharesource remote
patient monitoring from Baxter International Inc., a global innovator in renal
care.
Full Report Sample Here: - https://www.researchnester.com/reports/hemodialysis-and-peritoneal-dialysis-market/4271
Regional
Distribution of the Hemodialysis and Peritoneal
Dialysis Market
North America is estimated to dominate the market having the
largest revenue share of over 35.0% as shown in 2021. Kidney disease is the
ninth leading cause of death in the region. According to the Centers for
Disease Control and Prevention (CDC), a staggering 37 million Americans are
estimated to have kidney disease in the U.S. with almost 810,000
Americans living with kidney failure as of 2021 and 2 in every 1,000 people
needing dialysis or a kidney transplant to survive. In 2018, 554,038 patients received
dialysis to substitute kidney function and 229,887 got a kidney transplant.
About 130,000 people started KFRT (kidney failure with replacement therapy)
treatment in the same year, of which around 128,000 started dialysis as the
initial mode of therapy. Apart from that, the presence of key players and
government support is also boosting the market in this region.
The Asia Pacific region is
estimated to grow at the highest CAGR of 7.6% over the forecast period
considering the growing geriatric population in China, India, and Japan, the increasing
prevalence of kidney diseases, and the availability of advanced medical facilities.
Ø In 2017,
researchers estimated the total number of patients receiving dialysis in China
to be 581,273, with the prevalence of patients on hemodialysis being 384.41 per
million population and the prevalence of patients on peritoneal dialysis being
34.98 per million population. The number
of patients on dialysis in China has risen to approximately 744,817 in 2020 and
is expected to reach 874,373 patients by 2025.
Ø In India,
as per a study conducted in 2018, the number of patients on chronic dialysis in
India was around 175,000, showing a prevalence of 129 per million population. Hemodialysis
(HD) is the common mode of dialysis and the penetration of peritoneal dialysis
(PD) is very low. The number of HD stations in India in 2018 was estimated to
be 12,881 while there were only about 8500 patients on PD in India in 2019. The
union government announced a National Dialysis Program in 2016 that facilitated
the setting up of an eight-station dialysis facility in all 688 districts of
the country to provide HD to poor patients.
Ø The European Dialysis
Market size was valued at approximately USD 26 billion in 2021 and is
anticipated to exhibit a CAGR of 3.6% for the coming decade. Hemodialysis was
the preferred mode capturing around 91% of the market share in this region and is
estimated to grow with higher efficacy and more availability. Germany is considered
to lead the market in this region considering its reimbursement policies and
presence of advanced medical resources.
Request Report Sample@ https://www.researchnester.com/sample-request-4271
Conclusion:
In a nutshell, it can be said that dialysis
is an indispensable part of managing chronic kidney disease (CKD) to avoid further
deterioration of health. Hence the market for hemodialysis
and peritoneal dialysis is anticipated to advance in terms of revenue
generation for market players and investors in the coming decade. A recent report from Research
Nester gives a detailed account of the market’s potential
regarding its profitable growth.
About Research Nester
Research Nester is a leading service
provider for strategic market research and consulting. We aim to provide
unbiased, unparalleled market insights and industry analysis to help
industries, conglomerates and executives to take wise decisions for their
future marketing strategy, expansion and investment etc. We believe every
business can expand to its new horizon, provided a right guidance at a right
time is available through strategic minds. Our out of box thinking helps our
clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
No comments:
Post a Comment